NEPH
What one share of Nephros holds
Surgical and Medical Instruments and Apparatus
PFAS (a mixture of seven PFAS compounds including PFOA, PFOS, PFHxS, PFNA, PFHpA, PFBS, and PFDA), our portfolio of products is further enhanced with the ability to address a broad spectrum of emerging and persistent waterborne contaminants.
Nephros’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.86 |
|---|---|
| Profit | $0.16 |
| Cash and investments | $0.43 |
| Book value | $1.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.05 | −$0.06 | $0.00 | −$0.04 | — | $0.01 |
| 2017 | $0.07 | −$0.02 | — | −$0.00 | — | $0.04 |
| 2018 | $0.83 | −$0.50 | — | −$0.53 | — | $0.53 |
| 2019 | $1.37 | −$0.45 | $0.00 | −$0.30 | — | $0.58 |
| 2020 | $0.94 | −$0.53 | $0.03 | −$0.79 | — | $1.27 |
| 2021 | $1.02 | −$0.41 | $0.00 | −$0.14 | — | $1.14 |
| 2022 | $0.97 | −$0.72 | $0.01 | −$0.33 | — | $0.54 |
| 2023 | $1.37 | −$0.15 | $0.01 | $0.07 | — | $0.79 |
| 2024 | $1.34 | $0.01 | $0.01 | −$0.05 | — | $0.81 |
| 2025 | $1.71 | $0.11 | — | $0.15 | — | $0.96 |